Brief: Lantheus Holdings Expects To Release Data In Oct 2024 For Splash Trial Based On 75% Of Protocol-Specified Target Overall Survival Events Being Reached
25/09/2024 23:19
Sept 25 (Reuters) - Lantheus Holdings Inc LNTH.O :
* LANTHEUS HOLDINGS-EXPECTS TO RELEASE DATA IN OCT 2024 FOR
SPLASH
TRIAL BASED ON 75% OF PROTOCOL-SPECIFIED TARGET OVERALL SURVIVAL
EVENTS BEING REACHED
Source text for Eikon: ID:n0001193125-24-226113
Further company coverage: LNTH.O
((reuters.briefs@thomsonreuters.com;))
Recent news on Lantheus Holdings
See all newsStreet View: Lantheus' tumor kit setback seen as temporary, with growth catalysts still ahead
Brief: Lantheus Receives Complete Response Letter From FDA For Lnth-2501 (Ga 68 Edotreotide)
US FDA declines Lantheus’ tumor imaging kit over third-party manufacturing issues (updated)
US FDA declines to approve Lantheus’ tumor imaging kit
$7 billion could be a 'light' price tag for Lantheus, Truist analysts say